Earnings Feed
Start Free
Home/Filings/4/0001181431-05-041803
4//SEC Filing

NANOPHASE TECHNOLOGIES CORPORATION 4

Accession 0001181431-05-041803

$SLSNCIK 0000883107operating
View on SEC.govCompany Profile

Filed

Jul 24, 8:00 PM ET

Accepted

Jul 25, 4:27 PM ET

Size

24.2 KB

Accession

0001181431-05-041803

Insider Transaction Report

Form 4
Period: 2005-07-21
NANOPHASE TECHNOLOGIES CORPORATIONNANX
BROTZMAN RICHARD W
VP - Research & Development
Transactions
  • Exercise/Conversion

    Common Stock

    2005-07-21$1.73/sh+2,100$3,627→ 2,100 total
  • Exercise/Conversion

    Common Stock

    2005-07-21$3.89/sh+5,480$21,295→ 5,480 total
  • Sale

    Common Stock

    2005-07-21$6.85/sh−5,480$37,553→ 0 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2005-07-27$3.89/sh−5,480$21,295→ 64,000 total
    Exercise: $3.89From: 1997-11-07Exp: 2006-11-07→ Common Stock (69,480 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2005-07-21$1.73/sh−2,100$3,627→ 0 total
    Exercise: $1.73From: 1997-03-01Exp: 2006-03-01→ Common Stock (2,100 underlying)
  • Sale

    Common Stock

    2005-07-21$6.95/sh−2,100$14,595→ 0 total
Holdings

  • Stock Option (right to buy)

    Exercise: $7.69From: 2001-05-24Exp: 2010-05-24→ Common Stock (22,500 underlying)
    22,500

  • Common Stock

    1,500

  • Stock Option (right to buy)

    Exercise: $5.55From: 2005-10-11Exp: 2014-10-11→ Common Stock (11,000 underlying)
    11,000

  • Stock Option (right to buy)

    Exercise: $1.75From: 2000-07-27Exp: 2009-07-27→ Common Stock (15,000 underlying)
    15,000

  • Stock Option (right to buy)

    Exercise: $3.81From: 1999-07-31Exp: 2008-07-31→ Common Stock (40,600 underlying)
    40,600

  • Stock Option (right to buy)

    Exercise: $10.88From: 2002-01-26Exp: 2011-01-26→ Common Stock (20,000 underlying)
    20,000
Footnotes (3)
  • [F1]Subject to certain restrictions, beginning on this date, options vest in five equal installments.
  • [F2]Subject to certain restrictions, 51,485 of these options vest in five equal annual installments beginning on 11/07/1997, with the remainder vesting on 11/07/2004.
  • [F3]Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Documents

1 file

Issuer

NANOPHASE TECHNOLOGIES CORPORATION

CIK 0000883107

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000883107

Filing Metadata

Form type
4
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 4:27 PM ET
Size
24.2 KB
View on SEC.gov